Astria Therapeutics, Inc. Cash Flow Statement

Cash Flow Statement Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -18.12M-21.89M-32.64M-36.15M-27.40M-26.05M
Share-based Compensation 0.34M0.90M1.66M2.16M2.01M1.77M1.51M1.39M3.36M4.55M6.31M13.04M
Gains from Investment Securities 0.10M0.60M-0.00M0.05M0.28M0.43M-1.59M-0.06M-0.02M1.27M-0.05M5.75M
Non-cash Items 0.22M2.30M
Cash from Operations -16.37M-20.41M-29.79M-32.86M-26.84M-23.46M-26.57M-32.48M-30.15M-43.53M-68.44M-81.21M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.09M5.61M
Amortization of Deferred Charges 0.07M0.29M0.28M0.15M0.04M
Depreciation & Amortization (CF) 0.32M0.25M0.20M0.40M0.30M0.12M0.03M
Change in Working Capital
Change in Account Payables -0.13M0.48M0.20M0.08M-0.63M0.66M-0.21M0.35M-1.97M-0.77M0.72M2.81M
Change in Accured Expenses 1.16M0.01M0.95M0.42M-1.22M0.40M-0.20M1.59M-1.32M4.41M2.02M3.72M
Other Working Capital Changes -0.07M0.21M0.45M0.23M0.09M0.18M1.29M-1.26M-0.09M1.57M4.55M1.25M
Investing Activities
Capital Expenditures 0.04M0.23M0.42M0.46M0.06M0.02M0.01M0.03M0.02M0.09M0.03M0.33M
Sales of Property, Plant and Equipment 0.05M0.03M0.37M
Acquisitions 6.47M
Change in Acquisitions & Divestments 4.98M30.46M14.91M48.09M151.13M69.11M59.00M229.03M2059.50M4053.00M
Cash from Investing Activities -0.04M-0.23M-0.42M-15.49M14.88M-21.91M-4.08M6.30M-12.55M-167.13M135.05M-191.86M
Financing Activities
Other financing activities 0.28M0.01M
Cash from Financing Activities 41.45M4.83M78.33M9.16M4.73M44.30M25.62M40.86M104.28M144.72M88.40M157.20M
Additional items
Change in Cash 25.04M-15.81M48.11M-39.18M-7.23M-1.07M-5.03M14.68M61.58M-65.94M155.00M-115.87M
Free Cash Flow -16.41M-20.64M-30.21M-33.32M-26.89M-23.48M-26.58M-32.52M-30.17M-43.62M-68.47M-81.54M
Net Cash Flow 25.04M-15.81M48.11M-39.18M-7.23M-1.07M-5.03M14.68M61.58M-65.94M155.00M-115.87M